Leukodystrophies Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials
• Forums

Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
Conditions:   Vasculopathy, Retinal, With Cerebral Leukodystrophy;   Cerebroretinal Vasculopathy, HereditaryIntervention:   Drug: aclarubicinSponsor:   Washington University School of MedicineNot yet recruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2016 Category: Research Source Type: clinical trials